Biography
Megan was named to Global Competition Review’s 40 Under 40 for 2024, recognizing her among “the next generation of leading antitrust practitioners.” She was also recognized by Lawdragon 500 on its 2024 “X –The Next Generation” list, by Law360 as a 2023 “Rising Star,” by The National Journal as a 2021 “D.C. Rising Star,” and by Legal 500 as a Next Generation Partner. She has also been named a 2024 “Up & Coming” Lawyer in Antitrust by Chambers USA.
Megan obtained her J.D. from the University of Virginia School Of Law where she served on the editorial board of the Virginia Law & Business Review. She earned her B.S. in Commerce, with distinction, from the University of Virginia McIntire School of Commerce.
Key Representations:
- Microsoft on its investment in OpenAI.
- ChampionX Corporation in its pending $7.8 billion sale to SLB.
- Microsoft in its $68.7 billion acquisition of Activision Blizzard, Inc.
- Cedar Fair, L.P. in its $8 billion merger with Six Flags Entertainment.
- The Home Depot, Inc. in its $18.3 billion acquisition of SRS Distribution Inc.
- Sunoco LP in its $7.3 billion acquisition of NuStar Energy L.P.
- Meta Platforms (f/k/a Facebook) in numerous M&A related matters, including its $1 billion acquisition of Kustomer and its $400 million acquisition of Within.
- NEOGEN Corporation in its $5.3 billion combination with the Food Safety business of 3M.
- Microsoft in its $7.5 billion acquisition of ZeniMax Media, parent company of Bethesda Softworks and other game studios.
- Booking Holdings in its $1.2 billion acquisition of Getaroom, a B2B distributor of hotel rooms.
- BASF in its $11 billion acquisition of seed and herbicide assets pursuant to a DOJ antitrust consent decree in connection with Bayer’s acquisition of Monsanto.
- Blackstone Capital Partners and its portfolio company, PSAV, a global AV and event technology services provider, in its acquisition of Encore Event Technologies.
- Alfa S.A.B. de C.V. in the formation of Corpus Christi Polymers LLC (CCP), a joint venture among industry participants, and CCP’s $1.2 billion acquisition of an under-construction PET-PTA production facility in Corpus Christi, TX from M&G USA Corp.
- Walgreens Boots Alliance in its $4.4 billion acquisition of 1,932 Rite Aid stores.
- The Sherwin-Williams Company in its $11.3 billion acquisition of The Valspar Corporation.
- Campbell Soup Company in its $4.9 billion acquisition of Snyder’s-Lance.
- Biomet Inc., in its $13.4 billion sale to Zimmer Holdings, Inc.
- Kinder Morgan in its $38 billion acquisition of El Paso Corporation.
- The Sherwin-Williams Company in its acquisition of the US business of Comex.
- Bridgestone Corporation in a Department of Justice criminal investigation regarding the alleged bid rigging of automotive anti-vibration rubber parts.
Awards and Recognition, Speaking Engagements, Guides and Resources, Firm News & Announcements, Latest Thinking
Awards and Recognition
- Megan Granger Named to “X – The Next Generation” List Award Brief — Lawdragon 500 2024
- Megan Granger Named an “Up & Coming” Lawyer for Antitrust in Washington, D.C. Award Brief — Chambers USA
- Megan Granger Named a “Rising Star” in Competition Award Brief — Law360
- Megan Granger Named a “Next Generation Partner” in Merger Control Award Brief — Legal 500
- Weil Recognized in Global Competition Review's Matter of the Year for 2019 Award Brief — Global Competition Review Awards
Speaking Engagements
-
New Frontiers in Market Definition
Speaker(s):
Megan A. Granger
April 11, 2024 — Weil Antitrust partner Megan Granger participated on a panel at the ABA’s Antitrust Spring Meeting entitled “New Frontiers in Market Definition”. Panelists provided their views on market definition, legal and economic tools for defining markets, and how much market definitions still matter in today’s antitrust environment.”
-
Novel Theories of How Mergers Harm Competition
Speaker(s):
Megan A. Granger
November 14, 2023 — Weil Antitrust partner Megan Granger participated on a panel at Global Competition Review’s 2023 Women in Antitrust conference entitled “Novel Theories of How Mergers Harm Competition”. The panel discussed the increased evaluation of mergers by global competition authorities under new theories about how they are likely to lessen competition.
Firm News & Announcements
- Weil Advises DT Midstream in its $1.2 Billion Acquisition of Strategic Midwest FERC-Regulated Natural Gas Pipelines Deal Brief — November 20, 2024
- Megan Granger Named to Global Competition Review’s 40 Under 40 for 2024 Firm Announcement — September 05, 2024
Latest Thinking
- Antitrust Enforcement in Labor Markets: Merger Analysis at a Time of Agency Transition Alert — By John P. Barry, Megan A. Granger, Adam C. Hemlock, Eric S. Hochstadt, Brianne Kucerik, Michael Moiseyev, Jeffrey H. Perry, Jasmine Rosner, Kristin Sanford, John E. Scribner, Mark Seidman, Rebecca Sivitz, Jeff L. White, Joe Ehrenkrantz and Katie Rider — PDF — December 10, 2024
- Antitrust Enforcement in Trump’s Second Term: Policy Changes, Enforcement Priorities, and Leadership Turnover Alert — Antitrust — By Megan A. Granger, Adam C. Hemlock, Eric S. Hochstadt, Brianne Kucerik, Michael Moiseyev, Jeffrey H. Perry, Jasmine Rosner, Kristin Sanford, John E. Scribner, Mark Seidman, Jeff L. White, Charlotte McFaddin and Michael Geisler — PDF — November 18, 2024
- New HSR Rules, and Impact of Change in Administration Alert — Antitrust — By Megan A. Granger, Adam C. Hemlock, Eric S. Hochstadt, Brianne Kucerik, Michael Moiseyev, Jeffrey H. Perry, Jasmine Rosner, Kristin Sanford, John E. Scribner, Mark Seidman, Jeff L. White, Carla A. R. Hine and Michael C. Naughton — PDF — November 14, 2024
-
Federal Court Deals the FTC a Loss by Crediting Merging Companies’ Failing Firm Defenses and Commitments Regarding Post-Merger Conduct
Blog Post — WorthWeil Antitrust Blog
— By
Megan A. Granger
— June 18, 2024
Despite meeting its prima facie burden, the FTC failed in its attempt to block Novant’s acquisition of two struggling North Carolina hospitals. ...
-
FTC Case Against Healthcare Portfolio Company Proceeds; Sponsor Dismissed from Suit
Blog Post — WorthWeil Antitrust Blog
— By
Brianne Kucerik and
Megan A. Granger
— May 16, 2024
A Texas federal judge has dismissed the FTC’s high-profile suit against private equity firm Welsh Carson, but allowed the case to proceed against Welsh Carson’s portfolio company, U.S. Anesthesia Partners (USAP). You may recall that the FTC filed a complaint last September challenging allegedly anticompetitive conduct by USAP, as well as Welsh Carson [prior WorthWeil ...